Nutex Health Financials
| NUTX Stock | USD 34.76 0.54 1.58% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.65 | 1.5579 |
|
|
The essential information of the day-to-day investment outlook for Nutex Health includes many different criteria found on its balance sheet. An individual investor should monitor Nutex Health's cash flow, debt, and profitability to accurately make informed decisions on whether to invest in Nutex Health.
Net Income |
|
Nutex | Select Account or Indicator |
Understanding current and past Nutex Health Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nutex Health's financial statements are interrelated, with each one affecting the others. For example, an increase in Nutex Health's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Nutex Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nutex Health. Check Nutex Health's Beneish M Score to see the likelihood of Nutex Health's management manipulating its earnings.
Nutex Health Stock Summary
Nutex Health competes with FOXO Technologies, Heartbeam, EUDA Health, Privia Health, and Evolent Health. Nutex Health, Inc. operates as a technology-enabled healthcare services company. This divisions cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. Nutex Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 1500 people.Specialization | Health Care, Health Care Equipment & Services |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US67079U1088 |
| CUSIP | 67079U108 67079U306 67079U207 45173A103 18727D105 |
| Location | Florida; U.S.A |
| Business Address | 6030 South Rice |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.nutexhealth.com |
| Phone | 713 660 0557 |
| Currency | USD - US Dollar |
Nutex Health Key Financial Ratios
| Return On Equity | -0.35 | ||||
| Profit Margin | (0.14) % | ||||
| Operating Margin | 0.13 % | ||||
| Price To Sales | 0.65 X | ||||
| Revenue | 247.65 M |
Nutex Health Key Balance Sheet Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 179.2M | 308.6M | 394.7M | 431.8M | 398.2M | 418.2M | |
| Other Current Liab | 9.9M | 2.4M | 6.9M | 8.8M | 13.0M | 13.6M | |
| Net Debt | 111.9M | 124.6M | 142.4M | 232.9M | 253.8M | 266.4M | |
| Retained Earnings | (12.6M) | (18.2M) | 102.3M | (363.3M) | (409.1M) | (388.6M) | |
| Accounts Payable | 1.8M | 8.6M | 17.7M | 23.9M | 25.3M | 26.5M | |
| Cash | 8.0M | 25.5M | 36.1M | 34.3M | 22.0M | 12.7M | |
| Net Receivables | 36.1M | 108.1M | 114.8M | 58.3M | 62.8M | 41.9M | |
| Other Current Assets | 700.1K | 130.6K | 323.3K | 1.9M | 2.7M | 2.8M | |
| Total Liab | 128.4M | 161.2M | 203.1M | 311.4M | 319.1M | 335.1M | |
| Total Current Assets | 45.7M | 135.5M | 154.0M | 98.0M | 90.8M | 53.7M | |
| Common Stock | 4.6K | 5.3K | 592.8K | 650.2K | 676.7K | 710.5K | |
| Short Term Debt | 63.7M | 20.4M | 13.2M | 21.1M | 20.1M | 19.2M | |
| Intangible Assets | 2.6M | 1.5M | 682.6K | 21.2M | 20.5M | 21.5M | |
| Inventory | 899.9K | 1.7M | 2.8M | 3.5M | 3.4M | 2.3M |
Nutex Health Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Revenue | 97.1M | 273.4M | 331.5M | 219.3M | 247.6M | 129.0M | |
| Gross Profit | 95.4M | 271.6M | 179.3M | 13.5M | 34.8M | 54.7M | |
| Operating Income | 34.7M | 152.3M | 170.3M | (5.1M) | (31.8M) | (30.2M) | |
| Ebit | (7.0M) | (5.4M) | 175.7M | (407.2M) | (32.2M) | (33.8M) | |
| Ebitda | (6.8M) | (5.1M) | 183.4M | (394.0M) | (14.6M) | (15.3M) | |
| Cost Of Revenue | 1.7M | 1.8M | 152.3M | 205.8M | 212.9M | 223.5M | |
| Income Before Tax | 32.1M | 145.6M | 169.5M | (419.6M) | (48.5M) | (46.1M) | |
| Net Income | 16.5M | 106.0M | 132.6M | (432.7M) | (45.8M) | (43.5M) | |
| Income Tax Expense | 15.6M | 50.8M | 965.7K | 13.1M | (5.1M) | (4.8M) | |
| Interest Expense | 3.5M | 6.4M | 6.2M | 12.5M | 16.3M | 17.1M | |
| Research Development | 545.2K | 768.1K | 557.3K | 285.9K | 328.8K | 480.1K |
Nutex Health Key Cash Accounts
Cash flow analysis captures how much money flows into and out of Nutex Health. It measures of how well Nutex is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Nutex Health brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Nutex had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Nutex Health has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | 2.6M | 17.5M | 10.6M | (1.9M) | (12.3M) | (11.6M) | |
| Free Cash Flow | (20.2M) | 20.1M | 136.5M | 36.0M | (8.2M) | (7.8M) | |
| Depreciation | 2.5M | 6.0M | 7.7M | 13.1M | 17.6M | 18.5M | |
| Other Non Cash Items | (596.9K) | (580.6K) | (5.5M) | 400.7M | 34.0M | 43.3M | |
| Capital Expenditures | 32.3M | 61.2M | 36.9M | 14.6M | 9.5M | 15.5M | |
| Net Income | 32.1M | 145.6M | 168.5M | (432.7M) | (45.8M) | (43.5M) | |
| End Period Cash Flow | 8.0M | 25.5M | 36.1M | 34.3M | 22.0M | 12.7M | |
| Change To Inventory | (486.3K) | (825.8K) | (1.1M) | (719.1K) | 142.7K | 149.8K |
Nutex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nutex Health's current stock value. Our valuation model uses many indicators to compare Nutex Health value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nutex Health competition to find correlations between indicators driving Nutex Health's intrinsic value. More Info.Nutex Health is regarded fifth in return on equity category among its peers. It is regarded second in return on asset category among its peers . At this time, Nutex Health's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nutex Health's earnings, one of the primary drivers of an investment's value.Nutex Health Systematic Risk
Nutex Health's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Nutex Health volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Nutex Health correlated with the market. If Beta is less than 0 Nutex Health generally moves in the opposite direction as compared to the market. If Nutex Health Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Nutex Health is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Nutex Health is generally in the same direction as the market. If Beta > 1 Nutex Health moves generally in the same direction as, but more than the movement of the benchmark.
Today, most investors in Nutex Health Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Nutex Health's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Nutex Health growth as a starting point in their analysis.
Price Earnings To Growth Ratio |
|
Nutex Health November 27, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Nutex Health help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Nutex Health. We use our internally-developed statistical techniques to arrive at the intrinsic value of Nutex Health based on widely used predictive technical indicators. In general, we focus on analyzing Nutex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Nutex Health's daily price indicators and compare them against related drivers.
| Downside Deviation | 5.8 | |||
| Information Ratio | 0.0914 | |||
| Maximum Drawdown | 47.75 | |||
| Value At Risk | (9.19) | |||
| Potential Upside | 11.24 |
Additional Tools for Nutex Stock Analysis
When running Nutex Health's price analysis, check to measure Nutex Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nutex Health is operating at the current time. Most of Nutex Health's value examination focuses on studying past and present price action to predict the probability of Nutex Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nutex Health's price. Additionally, you may evaluate how the addition of Nutex Health to your portfolios can decrease your overall portfolio volatility.